AbCellera Biologics and Vertex Pharmaceuticals Deal Potential

The potential for AbCellera Biologics (ABCL)'s deal with Vertex Pharmaceuticals Incorporated (VRTX) to transform its TCE platform into a breakthrough is being examined.